眼科診療ビジュアルラーニング　5　網膜・硝子体

出版社： 中山書店
著者：
発行日： 2020-09-10
分野： 臨床医学：外科  >  眼科学
ISBN： 9784521745145
電子書籍版： 2020-09-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

12,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

12,100 円(税込)

購入する

商品紹介

糖尿病網膜症や網膜血管閉塞症などの血管性病変，杆体錐体ジストロフィなどの遺伝性疾患，裂孔原性網膜剥離などを含めて，広く網膜疾患をとりあげた．
眼底自発蛍光やOCT Angiographyなど，新しい検査手法による所見が満載．
加齢黄斑変性，黄斑ジストロフィなどは本シリーズ「6.　黄斑部」に譲った．

目次

  • 1　基礎編
    　解剖と構造
    　生理と機能
    　検査法とその選択
    　治療法の概要

    2　診断編
    　網膜血管病変
    　網膜剥離
    　変性疾患
    　発達障害
    　炎症性疾患
    　腫瘍性疾患
    　転移性脈絡膜腫瘍

    3　診療編
    　血管性病変／単純糖尿病網膜症
    　血管性病変／増殖前糖尿病網膜症
    　血管性病変／増殖糖尿病網膜症
    　血管性病変／糖尿病黄斑浮腫
    　血管性病変／網膜中心静脈閉塞症
    　血管性病変／網膜静脈分枝閉塞症
    　血管性病変／網膜中心静脈閉塞症
    　血管性病変／網膜動脈分枝閉塞症
    　血管性病変／Coats病
    　血管性病変／Eales病
    　血管性病変／網膜細動脈瘤
    　血管性病変／高血圧網膜症，腎性網膜症
    　血管性病変／眼虚血症候群
    　血管性病変／放射線網膜症
    　血管性病変／未熟児網膜症
    　血管性病変／膠原病による網膜症
    　血管性病変／白血病網膜症，貧血網膜症
    　遺伝性網脈絡膜疾患／網膜色素変性
    　遺伝性網脈絡膜疾患／Leber先天黒内障
    　遺伝性網脈絡膜疾患／錐体（杆体）ジストロフィ
    　遺伝性網脈絡膜疾患／クリスタリン網膜症
    　伝性網脈絡膜疾患／白点状眼底
    　伝性網脈絡膜疾患／小口病
    　遺伝性網脈絡膜疾患／先天停在性夜盲
    　遺伝性網脈絡膜疾患／先天網膜分離症
    　遺伝性網脈絡膜疾患／家族性滲出性硝子体網膜症
    　網膜剥離，脈絡膜剥離／裂孔原性網膜剥離
    　網膜剥離，脈絡膜剥離／増殖硝子体網膜症
    　網膜剥離，脈絡膜剥離／脈絡膜剥離
    　炎症，自己免疫性，腫瘍／悪性腫瘍随伴網膜症
    　炎症，自己免疫性，腫瘍／多発消失性白点症候群
    　炎症，自己免疫性，腫瘍／急性帯状潜在性網膜外層症（AZOOR）
    　炎症，自己免疫性，腫瘍／点状脈絡膜内層症（PIC）
    　炎症，自己免疫性，腫瘍／地図状脈絡膜炎（SC）
    　炎症，自己免疫性，腫瘍／急性後部多発性斑状色素上皮症（APMPPE）
    　炎症，自己免疫性，腫瘍／網膜芽細胞腫
    　炎症，自己免疫性，腫瘍／網膜血管腫

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 基礎編

P.11 掲載の参考文献
1) Spaide RF, et al : Anatomical correlates to the bands seen in the outer retina by optical coherence tomography : literature review and model. Retina 2011 ; 31 : 1609-1619.
 
2) Staurenghi G, et al : Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography : the IN・OCT consensus. International Nomenclature for Optical Coherence Tomography (IN・OCT) Panel. Ophthalmology 2014 ; 121 : 1572-1578.
 
P.66 掲載の参考文献
1) Early Treatment for Retinopathy of Prematurity Cooperative Group : Revised indications for the treatment of retinopathy of prematurity. Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003 ; 121 : 1684-1696.
PubMed

2 診断編

P.140 掲載の参考文献
1) 林孝彰 : 全色盲. あたらしい眼科 2011 ; 28 : 969-973.
Medical*Online
P.147 掲載の参考文献
1) Miyake Y, et al : Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 1986 ; 104 : 1013-1020.
PubMed

3 診療編

P.179 掲載の参考文献
1) 日本糖尿病眼学会 https://www.jsod.jp/member/guideline.html
 
P.182 掲載の参考文献
1) Wilkinson CP, et al : Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003 ; 110 : 1677-1682.
PubMed
2) Japanese Society of Ophthalmic Diabetology SotSoDRT ; Sato Y, et al : Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy. Jpn J Ophthalmol 2012 ; 56 : 52-59.
PubMed
P.186 掲載の参考文献
1) 日本緑内障学会緑内障診療ガイドライン作成委員会 : 緑内障診療ガイドライン (第4版). 日本眼科学会雑誌 2018 ; 122 : 3-52.
 
2) Aleman I, et al : Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy : a randomized and controlled trial. Br J Ophthalmol 2019 ; 103 : 1740-1746.
PubMed
P.190 掲載の参考文献
1) Early Treatment Diabetic Retinopathy Study research group : Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985 ; 103 : 1796-1806.
 
2) Jonas JB, et al : Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003 ; 121 : 57-61.
PubMed
3) Haritoglou C, et al : Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006 ; 26 : 999-1005.
PubMed
4) Diabetic Retinopathy Clinical Research Network, Elman MJ, et al : Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117 : 2010 ; 1064-1077.
 
5) Korobelnik JF, et al : Intravitreal aflibercept for diabetic macular edema. Ophthalmology 2014 ; 121 : 2247-2254.
PubMed
6) Terasaki H, et al : Management of Diabetic Macular Edema in Japan : A Review and Expert Opinion. Jpn J Ophthalmol 2018 ; 62 : 1-23.
PubMed
7) Wong TY, et al : Guidelines on Diabetic Eye Care : The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology 2018 ; 125 : 1608-1622.
PubMed
8) Nguyen QD, et al : Ranibizumab for diabetic macular edema : results from 2 phase III randomized trials : RISE and RIDE. Ophthalmology 2012 ; 119 : 789-801.
PubMed
9) Prunte C, et al : Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema : the RETAIN study. Br J Ophthalmol 2016 ; 100 : 787-795.
 
10) 小椋祐一郎ら : 黄斑疾患に対する硝子体内注射ガイドライン. 日本眼科学会雑誌 2016 ; 120 : 87-90.
 
11) Jonas JB, et al : Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 2005 ; 24 : 587-611.
PubMed
P.194 掲載の参考文献
1) Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol (Chicago, III : 1960) 1997 ; 115 : 486-491.
 
2) A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N Report. Ophthalmology 1995 ; 102 : 1434-1444.
 
3) Brown DM, et al : Ranibizumab in preproliferative (ischemic) central retinal vein occlusion : the rubeosis anti-VEGF (RAVE) trial. Retina 2014 ; 34 : 1728-1735.
PubMed
P.199 掲載の参考文献
1) Tan MH, et al : Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. Am J Ophthalmol 2014 ; 157 : 237-247.
PubMed
2) The Branch Vein Occlusion Study Group : Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch retinal vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986 ; 104 : 34-41.
 
3) Hasegawa T, et al : Clinical findings of eyes with macular edema associated with branch retinal vein occlusion refractory to ranibizumab. Retina 2018 ; 38 : 1347-1353.
PubMed
4) Iesato Y, et al : Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment. Jpn J Ophthalmol 2016 ; 60 : 86-94.
PubMed
5) Tomiyasu T, et al : Microaneurysms cause refractory macular edema in branch retinal vein occlusion. Sci Rep 2016 ; 6 : 29445.
PubMed
P.206 掲載の参考文献
1) Hayreh SS, et al : Hemi-Central Retinal Vein Occlusion Pathogenesis, Clinical Features, and Natural History. Arch Ophthalmol 1980 ; 98 : 1600-1609.
PubMed
2) Hayreh SS, et al : Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Greafes Arch Clin Exp Ophthalmol 1990 ; 228 : 201-217.
PubMed
3) Brown DM, et al : Ranibizumab in preproliferative (ischemic) central retinal vein occlusion : the rubeosis anti-VEGF (RAVE) trial. Retina 2014 ; 34 : 1728-1735.
PubMed
4) The Central Vein Occlusion Study Group M report : Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion. Ophthalmology 1995 ; 102 : 1425-1433.
 
5) Campochiaro PA, et al : Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion : The RELATE Trial. Ophthalmology 2015 ; 122 : 1426-1437.
 
6) The Central Vein Occlusion Study Group N report : A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995 ; 102 : 1434-1444.
 
7) Muraoka Y, et al : Foveal Damage Due to Subfoveal Hemorrhage Associated With Branch Retinal Vein Occlusion. PLoS One 2015 ; 14 : e0144894.
 
8) Kida T, et al : Cotton Wool Spots after Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Central Retinal Vein Occlusion. Ophthalmologica 2016 ; 235 : 106-113.
PubMed
P.210 掲載の参考文献
1) Hayreh SS : Ocular vascular occlusive disorders : natural history of visual outcome. Prog Retin Eye Res 2014 ; 41 : 1-25.
PubMed
2) Hayreh SS, et al : Retinal artery occlusion : associated systemic and ophthalmic abnormalities. Ophthalmology 2009 ; 116 : 1928-1936.
PubMed
3) Mason JO, et al : Branch retinal artery occlusion : visual prognosis. Am J Ophthalmol 2008 ; 146 : 455-457.
PubMed
P.215 掲載の参考文献
1) Yang X, et al : Recent advances in the diagnosis and treatment of Coats' disease. Int Ophthalmol 2019 ; 39 : 957-970.
PubMed
2) Morris B, et al : A population-based study of Coats disease in the United Kingdom I : epidemiology and clinical features at diagnosis. Eye 2010 ; 24 : 1797-1801.
 
3) Shields JA, et al : Classification and management of Coats disease : the 2000 Proctor Lecture. Am J Ophthalmol 2001 ; 131 : 572-583.
PubMed
4) Daruich AL, et al : SUBFOVEAL NODULE IN COATS' DISEASE : Toward an Updated Classification Predicting Visual Prognosis. Retina 2017 ; 37 : 1591-1598.
PubMed
5) Sen M, et al : Coats disease : An overview of classification, management and outcomes. Indian J Ophthalmol 2019 ; 67 : 763-771.
PubMed
P.219 掲載の参考文献
1) Biswas J, et al : Eales Disease-An Update. Surv Ophthalmol 2002 ; 47 : 197-214.
PubMed
2) Biswas J, et al : Eales' Disease-Current Concepts in Diagnosis and Management. J Ophthalmic Inflamm Infect 2013 ; 3 : 11.
PubMed
3) Chanana B, et al : Role of Intravitreal Bevacizumab in the Management of Eales' Disease. Int Ophthalmol 2010 ; 30 : 57-61.
PubMed
4) Patwardhan SD, et al : Role of Intravitreal Bevacizumab in Eales Disease With Dense Vitreous Hemorrhage : A Prospective Randomized Control Study. Retina 2011 ; 31 : 866-870.
PubMed
5) 加賀郁子ら : 関西医大附属病院におけるEales 病の臨床像の検討. あたらしい眼科 2017 ; 34 : 868-873.
 
6) Saxena S, et al : New classification system-based visual outcome in Eales' disease. Indian J Ophthalmol 2007 ; 55 : 267-269.
PubMed
P.223 掲載の参考文献
1) Lavin MJ, et al : Retinal arterial macroaneurysms : a retrospective study of 40 patients. Br J Ophthalmol 1987 ; 71 : 817-825.
PubMed
2) Tonotsuka T, et al : Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol 2003 ; 47 : 498-502.
PubMed
3) Sagara N, et al : Macular hole formation after macular haemorrhage associated with rupture of retinal arterial macroaneurysm. Br J Ophthalmol 2009 ; 93 : 1337-1340
 
P.234 掲載の参考文献
1) Maguire A, et al : chapter 83. Section 5. Ryan S, et al. RETINA fourth edition. Elsevier ; 2005. p.1483-1489.
 
2) 園田康平 : 放射線網膜症. 今日の眼疾患治療指針 第2版. 東京 : 医学書院 ; 2007. p.560.
 
P.238 掲載の参考文献
1) Stahl A, et al : Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW) : an open-label randomized controlled trial. Lancet 2019 ; 394 : 1551-1559.
PubMed
2) Anand N, et al : Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS 2019 ; 23 : 88.e1-88.e6.
 
3) Mintz-Hittner HA, et al : Review of effects of anti-VEGF treatment on refractive error. Eye Brain 2016 ; 15 : 135-140.
 
4) Mintz-Hittner HA, et al : Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy. Ophthalmology 2016 ; 123 : 1845-1855.
PubMed
P.243 掲載の参考文献
1) Klinkhoff AV, et al : Retinopathy in systemic lupus erythematosus : relationship to disease activity. Arthritis Rheum 1986 ; 29 : 1152-1156.
PubMed
2) 田宮宗久ら : 全身性エリテマトーデスの眼合併症. 臨床眼科 1993 ; 47 : 1533-1536.
 
3) Stafford-Brady FJ, et al : Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 1988 ; 31 : 1105-1110.
PubMed
4) Silpa-Archa S, et al : Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol 2016 ; 100 : 135-141
 
5) 榎本寛子ら : ヒドロキシクロロキン網膜症. あたらしい眼科 2018 ; 35 : 1329-1334
 
P.245 掲載の参考文献
1) Kincaid MC, et al : Ocular and orbital involvement in leukemia. Surv Ophthalmol 1983 ; 27 : 211-232.
PubMed
2) Katherine E, et al : Ophthalmic manifestations of leukemia. Curr Opin Ophthalmol 2016 ; 27 : 545-551.
 
P.248 掲載の参考文献
1) Holt JM, et al : Retinal abnormalities in diseases of the blood. Br J Ophthalmol 1969 ; 53 : 145-160.
PubMed
2) Selvan H, et al : Retinopathy in severe aplastic anemia. BMJ Case Reports 2019.
PubMed
P.255 掲載の参考文献
1) Grover S, et al : Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006 ; 141 : 850-858.
PubMed
2) Ikeda Y, et al : Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 2013 ; 97 : 1187-1191.
PubMed
3) Shimokawa S, et al : Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa. Ophthalmol Retina (in press)
 
4) Ikeda Y, et al : Night-vision aid using see-through display for patients with retinitis pigmentosa. Jpn J Ophthalmol 2019 ; 63 : 181-185.
PubMed
5) Kitahata S, et al : Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa. BMJ Open Ophthalmol 2018 ; 3 : e000107.
PubMed
6) Hagiwara A, et al : Macular abnormalities in patients with retinitis pigmentosa : prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol 2011 ; 89 : e122-125.
PubMed
P.259 掲載の参考文献
1) Kuniyoshi K, et al : Leber congenital amaurosis/early-onset retinal dystrophy in Japanese population. In : Prakash G, et al, editors : Advances in vision research, volume I. Genetic eye research in Asia and the Pacific. Tokyo : Springer ; 2017. p.137-167.
 
2) Nash BM, et al : Retinal dystrophies, genomic application in diagnosis and prospects for therapy. Transl Pediatr 2015 ; 4 : 139-163.
PubMed
P.264 掲載の参考文献
1) Fujinami K, et al : A longitudinal study of Stargardt disease : clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol 2013 ; 155 : 1075-1088 e13.
 
2) Fujinami K, et al : The clinical effect of homozygous ABCA4 alleles in 18 patients. Ophthalmology 2013 ; 120 : 2324-2331.
PubMed
3) Fujinami K, et al : Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am J Ophthalmol 2013 ; 156 : 487-501 e1.
 
4) Fujinami K, et al : Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology 2015 ; 122 : 326-334.
PubMed
5) Fujinami-Yokokawa Y, et al : Prediction of Causative Genes in Inherited Retinal Disorders from Spectral-Domain Optical Coherence Tomography Utilizing Deep Learning Techniques. J Ophthalmol 2019 ; 2019 : 1691064.
PubMed
6) Kameya S, et al : Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort : Cone Dystrophy With Normal Funduscopic Appearance. Invest Ophthalmol Vis Sci 2019 ; 60 : 3432-3446.
PubMed
7) Liu X, et al : East Asia Inherited Retinal Disease Consortium (EAIRDc). Stargardt disease in Asian population. Advances in Vision Research, Volume II. Tokyo : Springer ; 2019. p.279-296.
 
8) Yang L, et al : Genetic Spectrum of EYS-associated Retinal Disease in a Large Japanese Cohort : Identification of Disease-associated Variants with Relatively High Allele Frequency. Sci Rep 2020 ; 10 : 5497.
 
9) Fujinami-Yokokawa Y, et al : Clinical and Genetic Characteristics of 18 Patients From 13 Japanese Families With CRX-associated Retinal Disorder : Identification of Genotype-phenotype Association. Sci Rep 2020 ; 10 : 9531.
PubMed
10) Liu X, et al : Clinical and Genetic Characteristics of 15 affected patients from 12 Japanese Families with GUCY2D-associated retinal disorder. Transl Vis Sci Technol 2020 in press.
 
P.269 掲載の参考文献
1) GP Garcia-Garcia, et al : Current perspectives in Bietti crystalline dystrophy. Clin Ophthalmol 2019 ; 13 : 1379-1399.
 
2) Wada Y, et al : Screening for mutations in CYP4V2 gene in Japanese patients with Bietti's crystalline corneoretinal dystrophy. Am J Ophthalmol 2005 ; 139 : 894-899.
PubMed
3) Li A, et al : Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 2004 ; 74 : 817-826.
PubMed
4) Hata M, et al : Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes. Proc Natl Acad Sci U S A 2018 ; 115 : 3936-3941.
PubMed
5) Kojima H, et al : Outer Retinal Circular Structures in Patients With Bietti Crystalline Retinopathy. Br J Ophthalmol 2012 ; 96 : 390-393.
PubMed
P.273 掲載の参考文献
1) 厚生労働科学研究費補助金難治性疾患政策研究事業網膜脈絡膜・視神経萎縮症に関する調査研究班 網膜色素変性診療ガイドライン作成ワーキンググループ : 網膜色素変性診療ガイドライン. 日本眼科学会雑誌 2016 ; 120 : 846-861.
 
P.277 掲載の参考文献
1) 小口芳久 : 50年前の眼底スライド. 日本の眼科 2020 ; 91 : 442-443.
 
2) Nishiguchi KM, et al : Progression from classical Oguchi disease to retinitis pigmentosa after 50 years. Ophthalmology 2020 ; 127 : 51.
PubMed
3) Nishiguchi KM, et al : Phenotypic features of Oguchi disease and retinitis pigmentosa in patients with S-antigen (SAG) mutations : A Long-term Follow-up Study. Ophthalmology 2019 ; 126 : 1557-1566.
 
4) Nishiguchi KM, et al : Signs of Oguchi disease and pigmentary degeneration from early in life. Ophthalmology 2020 ; 127 : 825.
PubMed
P.281 掲載の参考文献
1) Miyake Y, et al : Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 1986 ; 104 : 1013-1020.
PubMed
P.286 掲載の参考文献
1) Hayashi T, et al : Four Japanese male patients with juvenile retinoschisis : only three have mutations in the RS1 gene. Am J Ophthalmol 2004 ; 138 : 788-798.
PubMed
2) Katagiri S, et al : Clinical features of a toddler with bilateral bullous retinoschisis with a novel RS1 mutation. Am J Ophthalmol Case Rep 2017 ; 5 : 76-80.
PubMed
3) Kondo H, et al : Novel mutations in RS1 gene in Japanese patients with X-linked congenital retinoschisis. Hum Genome Var 2019 ; 6 : 3.
PubMed
4) Hayashi T, et al : Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity. Ophthalmology 2005 ; 112 : 2115-2122.
PubMed
P.290 掲載の参考文献
1) 東範行ら : 家族性滲出性硝子体網膜症の診療の手引き : 厚生労働省科学研究費補助金難治性疾患政策研究事業網膜脈絡膜・視神経萎縮症に関する調査研究. 日本眼科学会雑誌 2017 ; 121 : 478-497.
 
P.294 掲載の参考文献
1) Sakamoto T, et al : Japan-Retinal Detachment Registry Report I : preoperative findings in eyes with primary retinal detachment. Jpn J Ophthalmol 2020 ; 64 : 1-12.
PubMed
2) Baba T, et al : Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy : Japan-Retinal Detachment Registry Report IV. Br J Ophthalmol 2020. 2020 Apr 3. online ahead of print.
 
3) Nishitsuka K, et al : Preoperative factors to select vitrectomy or scleral buckling for retinal detachment in microincision vitrectomy era. Graefe's Arch Clin Exp Ophthalmol (in printing). 2020 May 19. online ahead of print.
 
4) Shu I, et al : Scleral buckling versus vitrectomy for young Japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery : real-world evidence from a multicentre study in Japan. Acta Ophthalmol 2019 ; 97 : e736-e741
 
P.299 掲載の参考文献
1) 園田祥三ら : 眼科プラクティス 30 理に適った網膜復位術. 東京 : 文光堂 ; 2009. p.26-31.
 
2) Pastor JC, et al : Proliferative Vitreoretinopathy : A New Concept of Disease Pathogenesis and Practical Consequences. Prog Retin Eye Res 2016 ; 51 : 125-155.
PubMed
3) Machemer R, et al : An updated classification of retinal detachment with proliferative vitreoretinopahy. Am J Ophthalmol 1991 ; 112 : 159-165.
PubMed
4) 佐藤孝樹ら : 眼手術学. 網膜・硝子体 II. 東京 : 文光堂 ; 2012. p.73-85.
 
5) 井上真 : 後眼部アトラス. 東京 : 総合医学社 ; 2019. p.236-237.
 
6) Diddie KR, et al : Anterior proliferative vitreoretinopathy in the silicone study. Silicone study report number 10. Ophthalmology 1996 ; 103 : 1092-1099.
PubMed
7) Garnier S, et al : Three hundred and sixty degree retinotomy for retinal detachments with severe proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 2013 ; 251 : 2081-2085.
PubMed
8) Pastor JC, et al : Proliferative vitreoretinopathy : risk factors and pathobiology. Prog Retin Eye Res 2002 ; 21 : 127-144.
PubMed
P.302 掲載の参考文献
1) 松井端夫 (訳) : Kanski網膜剥離. 東京 : 医学書院 ; 1998.
 
2) 前野貴俊 : 脈絡膜剥離合併. 瓶井資弘編. 専門医のための眼科診療クオリファイ 17 裂孔原性網膜剥離. 東京 : 中山書店 ; 2013. p.286-288.
 
P.307 掲載の参考文献
1) Chan JW : Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 2003 ; 48 : 12-38.
PubMed
2) Morgans CW, et al : TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci U S A 2009 ; 106 : 19174-19178.
PubMed
3) Koike C, et al : TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A 2010 ; 107 : 332-337.
PubMed
4) Dhingra A, et al : Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci 2011 ; 31 : 3962-3967.
 
5) Kondo M, et al : Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One 2011 ; 6 : e19911.
PubMed
6) Ueno S, et al : Clinical course of paraneoplastic retinopathy with anti-trpm1 autoantibody in Japanese cohort. Retina 2019 ; 39 : 2410-2418.
PubMed
P.314 掲載の参考文献
1) Jampol LM, et al : Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol 1984 ; 102 : 671-674.
PubMed
2) Tavallali A, et al : MEWDS, common cold of the retina. J Ophthalmic Vis Res 2017 ; 12 : 132-134.
PubMed
3) Marsiglia M, et al : Expanded clinical spectrum of multiple evanescent white dot syndrome with multimodal imaging. Retina 2016 ; 36 : 64-74.
PubMed
4) Matsui Y, et al : Changes in outer retinal microstructures during six month period in eyes with acute zonal occult outer retinopathy-complex. PLoS One 2014 ; 9 : e110592.
PubMed
5) Russell JF, et al : Masqueraders of multiple evanescent white dot syndrome (MEWDS). Int Ophthalmol 2020 ; 40 : 627-638.
PubMed
P.319 掲載の参考文献
1) Gass JD, et al : Acute zonal occult outer retinopathy : a long-term follow-up study. Am J Ophthalmol 2002 ; 134 : 329-339.
PubMed
2) 近藤峰生ら : AZOORの診断ガイドライン作成ワーキンググループ. 急性帯状潜在性網膜外層症 (AZOOR) の診断ガイドライン. 日本眼科学会雑誌 2019 ; 123 : 443-449.
 
3) Saito S, et al : Acute zonal occult outer retinopathy in Japanese patients : clinical features, visual function, and factors affecting visual function. PLoS One 2015 ; e0125133.
PubMed
4) Ando R, et al : Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy : novel subtype of multiple drusen. Am J Ophthalmol 2018 ; 196 ; 181-196.
 
P.323 掲載の参考文献
1) Watzke RC, et al : Punctate inner choroidopathy. Am J Ophthalmol 1984 ; 98 : 572-584.
PubMed
2) Saito A, et al : Indocyanine green angiography in a case of punctate inner choroidopathy associated with acute zonal occult outer retinopathy. Jpn J Ophthalmol 2007 ; 51 : 295-300.
 
3) Hirooka K, et al : Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol 2014 ; 14 : 73.
PubMed
P.327 掲載の参考文献
1) ぶどう膜炎診療ガイドライン作成委員会 : 地図状脈絡膜炎. ぶどう膜炎診療ガイドライン. 日本眼科学会雑誌 2019 ; 123 : 687-689.
 
2) Takahashi A, et al : Impaired circulation in the thickened choroid of a patient with serpiginous choroiditis. Ocul Immunol Inflamm 2014 ; 22 : 409-413.
PubMed
3) Hirooka K, et al : Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy. Jpn J Ophthalmol 2016 ; 60 : 172-178.
PubMed
4) Jones BE, et al : Relentless placoid chorioretinitis : A new entity or an unusual variant of serpiginous chorioretinitis? Arch Ophthalmol 2000 ; 118 : 931-938.
PubMed
P.331 掲載の参考文献
1) 日本眼炎症学会ぶどう膜炎診療ガイドライン作成委員会 : ぶどう膜炎診療ガイドライン. 日本眼科学会雑誌 2019 ; 123 : 635-696.
 
2) 岩田大樹ら : 白点症候群. あたらしい眼科 2017 ; 34 : 1725-1730.
Medical*Online
3) 大木玲子ら : 脳梗塞を併発した後部多発性斑状色素上皮症の1例. 日本眼科学会雑誌 2019 ; 123 : 969-976.
 
P.335 掲載の参考文献
1) 鈴木茂伸ら : 網膜芽細胞腫. 小児がん診療ガイドライン 2016年版 (日本小児血液・がん学会編). 東京 : 金原出版 ; 2016. p.153-197.
 
2) Brierley JD, et al, editors : TNM Classification of Malignant Tumors, 8th ed. Wiley Blackwell : 2016.
 
3) Shields CL, et al : Combined Chemoreduction and Adjuvant Treatment for Intraocular Retinoblastoma. Ophthalmology 1997 ; 104 : 2101-2111.
PubMed
4) Suzuki S, et al : Selective ophthalmic arterial injection therapy for intraocular retinoblastoma : The long-term prognosis. Ophthalmology 2011 ; 118 : 2081-2187.
 
P.341 掲載の参考文献
1) Singh AD, et al : Retinal capillary hemangioma : a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology 2001 ; 108 : 1907-1911.
PubMed
2) van der Horst-Schrivers ANA, et al : The incidence of consecutive manifestations in von Hippel-Lindau disease. Fam Cancer 2019 ; 18 : 369-376.
PubMed
3) Wong WT, et al : Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology 2008 ; 115 : 181-188.
 
4) Lonser RR, et al : von Hippel-Lindau disease. Lancet 2003 ; 361 : 2059-2067.
PubMed
5) Wiley HE, et al : Management of Retinal Hemangioblastoma in Von Hippel-Lindau Disease. Retina 2019 ; 39 : 2254-2263.
PubMed
6) Schmidt-Erfurth UM, et al : Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 2002 ; 109 : 1256-1266.
PubMed
7) Wong WT, et al : Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology 2008 ; 115 : 1957-1964.
PubMed
8) Gonzalez-Rodriguez B, et al : Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas : phase III clinical trial. BMJ Open Ophthalmol 2019 ; 4 : e000203.
 
9) Krzystolik K, et al : Pars Plana Vitrectomy in Advanced Cases of Von Hippel-Lindau Eye Disease. Retina 2016 ; 36 : 325-334.
 
10) Karacorlu M, et al : Therapeutic Outcomes after Endoresection of Complex Retinal Capillary Hemangioblastoma. Retina 2018 ; 38 : 569-577.
PubMed

書評

最近チェックした商品履歴

Loading...